본문 바로가기

Data Plus(+)

All 807,818 Page 31,857/80,782

검색

Contents

No Journal_name Subject Date DOI Author
489258 CLINICAL MEDICINE : JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON Prehabilitation 2019-11-01 10.7861/clinmed.2019-0257 Durrand James, Singh Sally J, Danjoux Gerry
489257 ONCOTARGETS AND THERAPY

A Retrospective Case Series Of High-Intensity Focused Ultrasound (HIFU) In Combination With Gemcitabine And Oxaliplatin (Gemox) On Treating Elderly Middle And Advanced Pancreatic Cancer

2019-11-01 10.2147/ott.s220299 Tao Shuang-fen, Gu Wen-hua, Gu Jian-chun, Zhu Mei-ling, Wang Qing, Zheng Lei-zhen
489256 CANCER MANAGEMENT AND RESEARCH

Synchronous Neoplastic Lesions In Referred Patients With Colorectal Cancer: A Retrospective Cohort Study

2019-11-01 10.2147/cmar.s229376 Li Shuai, Zhu Kongxi, Yu Weihua, Wang Yunxia, Wang Teng, Guo Shuang, Teng Guoxin, Guo Jianqiang
489255 CANCER MANAGEMENT AND RESEARCH

The Prognosis Of Peroxiredoxin Family In Breast Cancer

2019-11-01 10.2147/cmar.s229389 Wang Gang, Zhong Wan-Chao, Bi Yi-Hui, Tao Si-Yue, Zhu Hai, Zhu Hai-Xing, Xu A-Man
489254 NEURO-ONCOLOGY RARE-40. OUTCOMES AFTER PROTON THERAPY FOR SKULL-BASE CHORDOMA: A PROSPECTIVE STUDY | RARE-40. OUTCOMES AFTER PROTON THERAPY FOR SKULL-BASE CHORDOMA: A PROSPECTIVE STUDY 2019-11-01 10.1093/neuonc/noz175.963 Holtzman Adam, Rotondo Ronny, Rutenberg Michael, Indelicato Daniel, Rao Dinesh, Louis Debbie, Morris Christopher, Mendenhall William
489253 NEURO-ONCOLOGY EPID-02. HEIGHT AND THE RISK OF MENINGIOMA | EPID-02. HEIGHT AND THE RISK OF MENINGIOMA 2019-11-01 10.1093/neuonc/noz175.302 Yust-Katz Shlomit, Amiel Alexandra, Abu Shkara Ramiz, Siegal Tali, Twig Gilad
489252 NEURO-ONCOLOGY GENE-52. ANALYSIS OF RECURRENT MUTATIONS WITHIN CANCERS REVEALS PATTERNS OF DIRECTIONAL EVOLUTION IN BRAIN TUMORS | GENE-52. ANALYSIS OF RECURRENT MUTATIONS WITHIN CANCERS REVEALS PATTERNS OF DIRECTIONAL EVOLUTION IN BRAIN TUMORS 2019-11-01 10.1093/neuonc/noz175.454 Küçükosmanoglu Asli, L Van Der Borden Carolien, Noske David, Wurdinger Tom, Westerman Bart
489251 NEURO-ONCOLOGY NIMG-41. RAPID AND ACCURATE CREATION OF PATIENT-SPECIFIC COMPUTATIONAL MODELS FOR GBM PATIENTS RECEIVING OPTUNE THERAPY WITH CONVENTIONAL IMAGING (T1w/PD) | NIMG-41. RAPID AND ACCURATE CREATION OF PATIENT-SPECIFIC COMPUTATIONAL MODELS FOR GBM PATIENTS REC 2019-11-01 10.1093/neuonc/noz175.711 Wenger Cornelia, Sara Hershkovich Hadas, Tempel-Brami Catherine, Giladi Moshe, Bomzon Ze’ev
489250 NEURO-ONCOLOGY ACTR-52. PHASE 1 STUDY OF FT-2102, AN INHIBITOR OF MUTANT IDH1, IN PATIENTS WITH RELAPSED/REFRACTORY IDH1 MUTANT GLIOMAS: PRELIMINARY SAFETY AND CLINICAL ACTIVITY 2019-11-01 10.1093/neuonc/noz175.094 De la Fuente Macarena I, Colman Howard, Rosenthal Mark, Van Tine Brian A, Fonkem Ekokobe, Walbert Tobias, Milhem Mohammed, Lipford Kate, Forsyth Sanjeev, Guichard Sylvie, Brevard Julie, Mikhailov Yelena, Thomson Blythe, Monga Varun
489249 CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index 2019-11-01 10.1016/j.ctro.2019.07.001 Fiorino Claudio, Passoni Paolo, Palmisano Anna, Gumina Calogero, Cattaneo Giovanni M., Broggi Sara, Di Chiara Alessandra, Esposito Antonio, Mori Martina, Ronzoni Monica, Rosati Riccardo, Slim Najla, De Cobelli Francesco, Calandrino Riccardo, Di Muzio Nadia G.